 | Up a level |
Vidal, Liat; Gafter-Gvili, Anat; Salles, Gilles; Dreyling, Martin H.; Ghielmini, Michele; Hsu Schmitz, Shu-Fang; Pettengell, Ruth; Witzens-Harig, Mathias; Shpilberg, Ofer (2011). Rituximab maintenance for the treatment of patients with follicular lymphoma: An updated systematic review and meta-analysis of randomized trials. Journal of the National Cancer Institute JNCI, 103(23), pp. 1799-1806. Cary, N.C.: Oxford University Press 10.1093/jnci/djr418
Wuethrich, Patrick Y; Hsu Schmitz, Shu-Fang; Kessler, Thomas M; Thalmann, George N; Studer, Urs E; Stueber, Frank; Burkhard, Fiona C (2010). Potential influence of the anesthetic technique used during open radical prostatectomy on prostate cancer-related outcome: a retrospective study. Anesthesiology, 113(3), pp. 570-6. Hagerstown, Md.: Lippincott Williams & Wilkins 10.1097/ALN.0b013e3181e4f6ec
Hsieh, Ying-Hen; Chen, Cathy W.S.; Hsu Schmitz, Shu-Fang; King, Chwan-Chuan; Chen, Wei-Ju; Wu, Yi-Chun; Ho, Mei-Shang (2010). Candidate genes associated with susceptibility for SARS-coronavirus. Bulletin of mathematical biology, 72(1), pp. 122-132. New York, N.Y.: Academic Press 10.1007/s11538-009-9440-8
Martinelli, Giovanni; Hsu Schmitz, Shu-Fang; Utiger, Urs; Cerny, Thomas; Hess, Urs; Bassi, Simona; Okkinga, Emmie; Stupp, Roger; Stahel, Rolf; Heizmann, Marc; Vorobiof, Daniel; Lohri, Andreas; Dietrich, Pierre-Yves; Zucca, Emanuele; Ghielmini, Michele (2010). Long Term Follow-Up Of Patients With Follicular Lymphoma Receiving Single Agent Rituximab At Two Different Schedules In Trial SAKK 35/98. Journal of clinical oncology, 28(29), pp. 4480-4484. Alexandria, Va.: American Society of Clinical Oncology 10.1200/JCO.2010.28.4786
Morin, Benjamin R.; Castillo-Chavez, Carlos; Hsu Schmitz, Shu-Fang; Mubayi, Anuj; Wang, Xiahong (2010). Notes from the heterogeneous: A few observations on the implications and necessity of affinity. Journal of biological dynamics, 4(5), pp. 456-477. Abingdon, UK: Taylor & Francis 10.1080/17513758.2010.510212
Vidal, Liat; Gafter-Gvili, Anat; Leibovici, Leonard; Dreyling, Martin; Ghielmini, Michele; Hsu Schmitz, Shu-Fang; Cohen, Amos; Shpilberg, Ofer (2009). Rituximab Maintenance for the Treatment of Patients With Follicular Lymphoma: Systematic Review and Meta-analysis of Randomized Trials. Journal of the National Cancer Institute JNCI, 101(4), pp. 248-255. Cary, N.C.: Oxford University Press 10.1093/jnci/djn478
Schuller, Jan C.; Mayer, Michael; Lanz, Doris; Hsu Schmitz, Shu-Fang; Brauchli, Peter; Leupin, Nicolas (2009). A novel diagram and complement to the CONSORT chart for presenting multimodal clinical trials. Contemporary clinical trials, 30(3), pp. 201-204. New York, N.Y.: Elsevier 10.1016/j.cct.2009.01.010
Strasser, Florian; Demmer, Ruth; Böhme, Christel; Hsu Schmitz, Shu-Fang; Thuerlimann, Beat; Cerny, Thomas; Gillessen, Silke (2008). Prevention of Docetaxel- or Paclitaxel-Associated Taste Alterations in Cancer Patients with Oral Glutamine: A Randomized, Placebo-Controlled, Double-Blind Study. Oncologist, 13(3), pp. 337-346. Miamisburg, Ohio: AlphaMed Press 10.1634/theoncologist.2007-0217
Hsu Schmitz, Shu-Fang (2007). The Influence of Treatment- and Vaccination-induced Changes in the Risky Contact Rate on HIV Transmission. Mathematical population studies, 14(1), pp. 57-76. Philadelphia, Pa.: Routledge, Taylor & Francis Group 10.1080/08898480601090683
Hsu Schmitz, Shu-Fang; Mhawech-Fauceglia, P; Oberholzer, M; Aschenafi, S; Baur, A; Kurrer, M; von Rohr, A; Wagner, B; Delacretaz, F; Hurwitz, N (2006). Potential predictive patterns of minimal residual disease detected by immunohistochemistry on bone marrow biopsy specimens during a long-term follow-up in patients treated with cladribine for hairy cell leukemia. Archives of pathology & laboratory medicine(130), pp. 374-377. Northfield, Ill.: College of American Pathologists
Hsu Schmitz, Shu-Fang; Schuller, Jan; Mayer, Michael (2009). Design and analysis of early-phase clinical trials with intra-patient dose escalation. ROeS Seminar, September 14-17, 2009, Linz.
Schuller, Jan C.; Brauchli, Peter; Dietrich, Daniel; Herrmann, Richard; Klingbiel, Dirk; Lerch, Stefanie; Mayer, Michael; Simcock, Mathew; Hsu Schmitz, Shu-Fang (2009). Should phase II cancer screening trials include a control arm? 30th Annual Conference of the International Society for Clinical Biostatistics, August 23-27, 2009, Prague.
Ghielmini, Michele; Hsu Schmitz, Shu-Fang; Martinelli, Giovanni; Peccatori, F; Hess, Urs; Fey, Martin; Zucca, Emanuele; Stahel, Rolf; Ketterer, Nicolas; Cerny, Thomas (2009). Long-term follow-up of patients with follicular lymphoma (FL) receiving single agent rituximab at two different schedules in study SAKK 35/98. Journal of clinical oncology, 27(15), p. 8512. American Society of Clinical Oncology
Martinelli, Giovanni; Hsu Schmitz, Shu-Fang; Hess, Urs; Okkinga, Emmie; Stupp, Roger; Taverna, Christian; Vorobiof, Daniel; Heizman, Marc; Dietrich, Pierre-Yves; Ghielmini, Michele (2009). Long-term follow-up of follicular lymphoma (FL) patients receiving single agent rituximab at two different schedules in trial SAKK 35/98. European journal of cancer, 7(2), p. 562. Elsevier 10.1016/S1359-6349(09)71897-X
